Success Metrics

Clinical Success Rate
100.0%

Based on 10 completed trials

Completion Rate
100%(10/10)
Active Trials
0(0%)
Results Posted
0%(0 trials)

Phase Distribution

Ph phase_1
1
8%
Ph not_applicable
4
31%
Ph phase_3
3
23%
Ph phase_2
2
15%
Ph phase_4
2
15%

Phase Distribution

1

Early Stage

2

Mid Stage

5

Late Stage

Phase Distribution12 total trials
Phase 1Safety & dosage
1(8.3%)
Phase 2Efficacy & side effects
2(16.7%)
Phase 3Large-scale testing
3(25.0%)
Phase 4Post-market surveillance
2(16.7%)
N/ANon-phased studies
4(33.3%)

Highest Phase Reached

Phase 4

Trial Status & Enrollment

Completion Rate

100.0%

10 of 10 finished

Non-Completion Rate

0.0%

0 ended early

Currently Active

0

trials recruiting

Total Trials

13

all time

Status Distribution
Completed(10)
Other(3)

Detailed Status

Completed10
unknown3

Development Timeline

Analytics

Development Status

Total Trials
13
Active
0
Success Rate
100.0%
Most Advanced
Phase 4

Trials by Phase

Phase 11 (8.3%)
Phase 22 (16.7%)
Phase 33 (25.0%)
Phase 42 (16.7%)
N/A4 (33.3%)

Trials by Status

completed1077%
unknown323%

Recent Activity

Clinical Trials (13)

Showing 13 of 13 trials
NCT00483106Phase 4

Clinical and Pharmacogenetic Study of Attention Deficit With Hyperactivity Disorder (ADHD)

Completed
NCT02780102Not Applicable

Cognitive-Motor Rehabilitation, Stimulant Drugs, and Active Control in the Treatment of ADHD

Completed
NCT02265718

A Study To Evaluate The Difference In iPad-Based Cognitive Video Game (Akili Interactive's Project: EVO) Performance In Amyloid-Positive Versus Amyloid-Negative Healthy Elderly Volunteers

Completed
NCT03788902Not Applicable

OT and Social Cognition in Children With ADHD: Impact of MPH

Completed
NCT01831622Phase 4

Influence of Stimulant Medication on Brain Processes for Decision Making in Attention Deficit Hyperactivity Disorder

Completed
NCT01675804Phase 3

Computer-assisted Cognitive Rehabilitation (CACR), Placebo CACR and Psycho-stimulants in the Treatment of ADHD

Completed
NCT01962181Not Applicable

Identifying Characteristic Signature of Attention Deficit / Hyperactivity Disorder (ADHD) and Ritalin Treatment

Unknown
NCT00269789Phase 3

A Comparative Effectiveness Study Evaluating OROS Methylphenidate HCl, Ritalin (Methylphenidate HCl), and Placebo for the Treatment of Attention Deficit Hyperactivity Disorder in Children

Completed
NCT00269802Phase 3

A Multicenter Study Comparing the Efficacy and Safety of OROS Methylphenidate HCl, Ritalin (Methylphenidate HCl) and Placebo in Children With Attention Deficit Hyperactivity Disorder

Completed
NCT00485797Not Applicable

Effects of Ritalin on Postural Stability of Hyper Active Children

Completed
NCT01099059Phase 2

Amantadine Versus Ritalin in the Treatment of Attention Deficit Hyperactivity Disorder (ADHD)

Unknown
NCT00138138Phase 2

Psychostimulants for Fatigue in Prostate Cancer

Completed
NCT00220493Phase 1

Evaluation of Efficiency of Ritalin in Multiple Sclerosis (MS) Patients

Unknown

All 13 trials loaded

Drug Details

Intervention Type
DRUG
Total Trials
13